José Luis Durán graduated as a technician in industrial chemistry. He works on the purification of mAbs and therapeutic vaccines in the R&D BioProcess Development Department at the Center for Molecular Immunology in Havana.
Regulatory authorities have approved the use of recombinant monoclonal antibodies (mAbs) to treat infectious diseases1
and chronic conditions such as cancer
1Sparrow, E., M. Friede, M. Sheikh, and S. Torvaldsen. “Therapeutic Antibodies for Infectious Diseases.” Bulletin of the World Health Organization 95, no. 3 (2017):235–237. doi:10.2471/BLT.16.178061